Goldman Sachs Downgrades Aetna To Neutral

Analysts at Goldman Sachs downgraded Aetna

from Buy to Neutral. The target price for Aetna has been lowered from $94.00 to $88.00. Aetna shares have surged 24.00% over the past 52 weeks, while the S&P 500 index has gained 13.56% in the same period. Aetna's shares dropped 0.61% to $77.84 in pre-market trading.